| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | 0.0074 | 0.8 |
| mRNA | Axitinib | FIMM | pan-cancer | AAC | -0.033 | 0.8 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.0063 | 0.8 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.8 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | -0.0073 | 0.8 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.0096 | 0.8 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | -0.0074 | 0.8 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.8 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.01 | 0.8 |